Pharmbiotest visited the international exhibition in Milan
27 December 2022
Pharmbiotest representatives had been invited and hence took part in the prestigious international pharmaceutical exhibition CPhI Worldwide 2021 in Milan, Italy
The event has been visited by 1,400 companies from 170 countries of the world to demonstrate their inventions and meet new business partners.
The visitors had the chance to see the entire chain of pharmaceutical products supply from API-interfaces, equipment and packaging to outsourcing, finished products and biopharmaceuticals.
CPhI Worldwide is an outstanding event in the pharmaceutical industry, which brings together thousands of pharmaceutical industry professionals and suppliers from around the world. “It was very important for us as a company continuously searching for new and the most up-to-date working practices, and upgrading its knowledge in conducting clinical trials, laboratory services and logistics on a regular basis, to visit this exhibition and establish certain working relations with foreign companies”, said Grygorii Tsapko, Director of CDC Pharmbiotest. “Due to the possibility of exchanging experience with our foreign colleagues and implementing the most efficient practices Pharmbiotest steadily develops”.
Pharmbiotest is a modern medical research and development center focused on conducting comparative pharmacokinetic studies. At present Pharmbiotest is the only closed-cycle research company in Ukraine, which means that all the research stages (clinical, bioanalytical and statistical) are performed by the same legal entity that assures the quality of each and every procedure carried out.